Neurocognitive Function After Proton Therapy in Children and Adolescents — ELBE-ProKids  

Primary Brain Tumor Clinical Trial

Official title: Neurocognitive Function /Executive Functions After Proton Therapy in Children and Adolescents.

Status Recruiting

Clinical Trial Summary

Brain tumors are the second most frequent malignant diseases in children and adolescents. In the study the short and medium term consequences of proton therapy on cognitive processes in particular on executive functions in pediatric patients shall be highlighted/analysed/evalutated. In a second step, these results are to be compared with

1. a group of children and adolescents who had only /exclusively had operative therapy and

2. with a healthy control group. Thus, the extent to which these treatment options differ in terms of their short and medium-term effect is assessed. Methods of neurocognitive/neurophysiology brain research approaches are applied that may potentially visualize even small / subtle changes in mental activities/neurocognitive function. Therefore the effects of treatment can be evaluated and the neuropsychological outcome of children and adolescents with brain tumors can be improved.

Clinical Trial Description

Radio(chemo)therapy with protons is conducted according to current treatment standards or, for patients participating in a clinical intervention study, according to the study protocols of the GPOH. Only patients with prescribed radiation doses > 40 Gy (RBE) will be included. Treatment planning, the target volume and radiotherapy will be performed according to the current treatment standards. For patients participating in a clinical intervention study, radiotherapy is corresponding to study protocol of the GPOH. Risk organs (e.g. brain stem, chiasma, optic nerves, gll. Lacrimals, lenses, inner ears and spine) are contoured and the radiation doses for these organs are limited according to institutional guidelines. Radiotherapy is performed according to guidelines, i.e. 5 days a week for 4-6 weeks, usually on an outpatient basis. ;

Related Conditions & MeSH terms

• Brain Neoplasms
• Primary Brain Tumor

• NCT number: NCT04066465
• Study type: Observational
• Source: Technische Universität Dresden
• Contact: Mechthild Krause, Prof. Dr.
• Phone: +49 351 458 2238
• Email: mechthild.krause@uniklinikum-dresden.de
• Status: Recruiting
• Start date: September 1, 2019
• Completion date: December 31, 2027